Keyphrases
T Cells
100%
Canine
100%
Methotrexate
100%
Gene-modified
100%
In Vivo Protection
100%
Dihydrofolate Reductase Gene
100%
Immune Activation
25%
Nonmyeloablative
25%
Transplantation
25%
Engraftment
25%
Yellow Fluorescent Protein
25%
Fluorescent Reporter
12%
Clinically Significant
12%
Immunosuppression
12%
Clinical Translation
12%
Grafting from
12%
Allogeneic
12%
CD25+
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Methotrexate Resistance
12%
Immunomodulatory Effect
12%
Severe Combined Immunodeficiency
12%
Myeloablative Conditioning
12%
Non-cancer
12%
Pretransplant
12%
Surrogate Assay
12%
CD34+ Cells
12%
Myeloablative
12%
Green Fluorescent Protein
12%
Methylenetetrahydrofolate Reductase (MTHFR)
12%
Aplastic Anemia
12%
Activated T Cells
12%
CD4+ T Lymphocytes
12%
Hemoglobinopathies
12%
Graft Rejection
12%
Malignant Disease
12%
CD3+
12%
Green Fluorescent Protein Gene
12%
Lentivirus Vector
12%
Chemoprotection
12%
Methotrexate Treatment
12%
Hematopoietic System
12%
Allogeneic Cells
12%
Risk of Rejection
12%
Methotrexate Toxicity
12%
Foreign Antigen
12%
Medicine and Dentistry
T Lymphocyte
100%
Methotrexate
100%
Dihydrofolate Reductase
100%
T Cell
20%
Engraftment
20%
Yellow Fluorescent Protein
20%
Green Fluorescent Protein
20%
Immunosuppressive Treatment
10%
Graft Rejection
10%
Lentivirus Vector
10%
CD4+ T Lymphocyte
10%
Allogeneic Hematopoietic Stem Cell Transplantation
10%
Aplastic Anemia
10%
Hematological System
10%
Hemoglobinopathy
10%
Nonmyeloablative Conditioning
10%
CD3 Antigen
10%
Immunosuppressive Drug
10%
Severe Combined Immunodeficiency
10%
Diseases
10%
Immunology and Microbiology
Methotrexate
100%
T Cell
100%
Engraftment
20%
Immunosuppression
10%
Immunosuppressive Drug
10%
Severe Combined Immunodeficiency
10%
CD25
10%
CD34
10%
Conditioning
10%
Allogeneic Hematopoietic Stem Cell Transplantation
10%
Lentivirus Vector
10%
CD4+ T Lymphocyte
10%
Hematopoietic System
10%
Aplastic Anemia
10%
CD3 Antigen
10%